Global Starch Softgel Capsules Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Starch Softgel Capsules Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The starch soft gel capsules are usually derived from natural sources and are used as nutritional supplements for patients suffering from various medical conditions. These soft gel capsules are usually free of genetic modifications and are manufactured adhering to strict quality standards. The soft gel capsules are available in gelatin as well as non-gelatin composition for people with vegetarian and non-vegetarian preferences.
Starch Softgel Capsules report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Starch Softgel Capsules market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Supermarket and Hypermarket and Pharmacy and Drugstore are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Starch Softgel Capsules industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Starch Softgel Capsules key manufacturers include Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd., Procaps, CAPTEK Softgel International Inc., Softcaps, Fuji Capsule Co., Ltd., Aenova Holding GmbH and Sirio Pharma Co., Ltd., etc. Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
Starch Softgel Capsules can be divided into Gelatin Composition and Non-Gelatin Composition, etc. Gelatin Composition is the mainstream product in the market, accounting for % sales share globally in 2022.
Starch Softgel Capsules is widely used in various fields, such as Supermarket and Hypermarket, Pharmacy and Drugstore and Online Provider,, etc. Supermarket and Hypermarket provides greatest supports to the Starch Softgel Capsules industry development. In 2022, global % sales of Starch Softgel Capsules went into Supermarket and Hypermarket filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Starch Softgel Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Catalent Inc
Robinson Pharma, Inc.
Hunan Er-Kang Pharmaceutical Co., Ltd.
Procaps
CAPTEK Softgel International Inc.
Softcaps
Fuji Capsule Co., Ltd.
Aenova Holding GmbH
Sirio Pharma Co., Ltd.
Bahrain Pharma
Segment by Type
Gelatin Composition
Non-Gelatin Composition
Supermarket and Hypermarket
Pharmacy and Drugstore
Online Provider
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Starch Softgel Capsules market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Starch Softgel Capsules, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Starch Softgel Capsules industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Starch Softgel Capsules in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Starch Softgel Capsules introduction, etc. Starch Softgel Capsules Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Starch Softgel Capsules market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Starch Softgel Capsules report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Starch Softgel Capsules market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Supermarket and Hypermarket and Pharmacy and Drugstore are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Starch Softgel Capsules industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Starch Softgel Capsules key manufacturers include Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd., Procaps, CAPTEK Softgel International Inc., Softcaps, Fuji Capsule Co., Ltd., Aenova Holding GmbH and Sirio Pharma Co., Ltd., etc. Catalent Inc, Robinson Pharma, Inc., Hunan Er-Kang Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2022.
Starch Softgel Capsules can be divided into Gelatin Composition and Non-Gelatin Composition, etc. Gelatin Composition is the mainstream product in the market, accounting for % sales share globally in 2022.
Starch Softgel Capsules is widely used in various fields, such as Supermarket and Hypermarket, Pharmacy and Drugstore and Online Provider,, etc. Supermarket and Hypermarket provides greatest supports to the Starch Softgel Capsules industry development. In 2022, global % sales of Starch Softgel Capsules went into Supermarket and Hypermarket filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Starch Softgel Capsules market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Catalent Inc
Robinson Pharma, Inc.
Hunan Er-Kang Pharmaceutical Co., Ltd.
Procaps
CAPTEK Softgel International Inc.
Softcaps
Fuji Capsule Co., Ltd.
Aenova Holding GmbH
Sirio Pharma Co., Ltd.
Bahrain Pharma
Segment by Type
Gelatin Composition
Non-Gelatin Composition
Segment by Application
Supermarket and Hypermarket
Pharmacy and Drugstore
Online Provider
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Starch Softgel Capsules market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Starch Softgel Capsules, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Starch Softgel Capsules industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Starch Softgel Capsules in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Starch Softgel Capsules introduction, etc. Starch Softgel Capsules Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Starch Softgel Capsules market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices